See also this year's filing and all EDGAR filings for this company.
PDF Report 0000912183_2011_Cubist_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000912183, Cubist Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 1,016,243,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 75,304,000 |
| 2 | PropertyPlantAndEquipmentNet | 82,434,000 |
| 3 | remainder_Assets | 241,176,000 |
| 4 | LiabilitiesCurrent | 150,644,000 |
| 5 | LiabilitiesNoncurrent | 6,370,000 |
| 6 | remainder_Liabilities | 594,720,000 |
| 7 | CostOfGoodsAndServicesSold | 140,765,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 57,841,000 |
| 9 | ResearchAndDevelopmentExpense | 157,854,000 |
| 10 | remainder_Expenses | 150,383,000 |
| 11 | remainder_Revenues | 636,458,000 |
| 12 | remainder_NetIncome | -35,290,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,415,157,000 |
| 1 | Liabilities | 751,734,000 |
| 2 | Expenses | 506,843,000 |
| 3 | Revenues | 636,458,000 |
| 4 | StockholdersEquity | 663,423,000 |
| 5 | NetIncome | 94,325,000 |
| 6 | ComprehensiveNetIncome | 94,325,000 |
| 7 | BaseVar | 1,672,741,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.42 |
| 9 | EconomicCapitalRatio | 2.62 |
Edgar->Model Mapping
Feature Distribution
